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Introduction 
More and more evidence has been provided, that exposure 
of the heart to even low doses (0.5Gy) of ionizing radia-
tion significantly increase the risk for cardiovascular dis-
ease and in consequence leads to increased mortality [1-
4]. The term “cardiovascular disease” describes different 
types of pathologies which affect the cardiovascular sys-
tems (e.g. coronary heart disease, heart failure, etc.). Sev-
eral processes are discussed to be involved, e.g. pericar-
dial or myocardial fibrosis, accelerated atherosclerosis, 
etc. [4]. In this context the endothelial dysfunction plays 
an important role in promoting fibrotic and inflammatory 
processes after irradiation [5]. Endothelial dysfunction is 
mainly characterized by a loss of thrombo-resistence of 
the endothelium, which is accompanied by an increased 
expression of adhesion molecules and van-Willebrand 
factor [5]. However the cellular and molecular mecha-
nisms underlying the disease progression are not com-
pletely understood. Our part in this project is the investi-
gation of the modulation of cytokine release by EC of the 
cardiovascular system after irradiation with low doses of 
high- and low LET radiation, in collaboration with partner 
institutes within the Procardio project, namely: the Helm-
holtz centre Munich, Germany and the Health protection 
agency (HPA) Chilton, UK. 
Materials and Methods 
For irradiation experiments, primary cardiac microvascu-
lar endothelial cells (HCMEC) were obtained from 
Lonza. In a first experiment, the cells have been irradiated 
with γ-rays at Helmholtz centre Munich and with nickel 
ions (175keV/µm) at GSI facilities (Darmstadt, Ger-
many). Supernatant was taken 4 and 24h after irradiation 
and stored at -80°C. Measurements of the cytokine con-
centration were performed with ELISA technique and 
multiplex bead arrays (both from eBiosciences).  
Results and Conclusion 
The results of the first experiment where monocultures of 
HCMEC have been irradiated with nickel ions are shown 
in Figure 1. Measurements of the concentration of more 
than 20 cytokines or chemokines (e.g. TNF-α, MCP-1, 
MIP-1, IL-1α, IL-6, IL-8 etc.) revealed a tendency for a 
increased release of 2 chemokines (MCP-1 and IL-8) 24h 
after exposure, already at a dose of 0.5Gy. The other fac-
tors that have been investigated remained unchanged or 
the changes were statistically not significant (data not 
shown). No significant changes have been detected for all 
cytokines and chemokines measured after γ-exposure (not 
shown).  
 
 
Figure 1: Relative release of MCP-1 (A) or IL-8 (B) of 
HCMEC 4 and 24h after irradiation with nickel ions (LET: 
175keV/µm). (N=1, n=2) 
The tendency for an increased release of the chemokines 
MCP-1 and IL-8 clearly points to an inflammatory reac-
tion of HCMEC even after irradiation with low doses of 
ionizing radiation. The chemokine MCP-1 is mainly re-
sponsible to trigger monocyte recruitment into inflamed 
tissue [6], whereas IL-8 is responsible for recruitment of 
neutrophils and T-cells [7]. The higher amount of 
chemokines points to an increased migration of immune 
cells into the heart tissue after exposure to ionizing radia-
tion, which than in turn could promote inflammatory 
processes like fibrosis or endothelial dysfunction. In fu-
ture experiments the release of chemokines will be as-
sessed more in detail, to clarify if the effect is statistically 
significant. As a next step the question will be addressed 
if a co-cultivation with other relevant cell types influences 
the responding cytokine/chemokine release.  
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